Machine Learning Modeling of Intraoperative Hemodynamic Predictors of Postoperative Outcomes

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

35000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-01-01

Study Completion Date

2017-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

With population aging and limited resources, strategies to improve outcomes after surgery are ever more important. There is a limited understanding of what ranges of hemodynamic variables under anesthesia are associated with better outcomes. This retrospective cohort study will analyze how hemodynamic variables during surgeries predict mortality, morbidity, Intensive Care Unit admission, length of hospital stay, and hospital readmission. The use of machine learning in a large, broad surgery population dataset could detect new relationships and strategies that may inform current practice, and generate ideas for future research.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Effects of Individualized Oxygen Dynamic on Prognosis of Patients With High-risk Cardiac Surgery

NCT03103633

Cardiac Disease High Risk Sex

COMPLETED NA

Derivation and Validation of Hemodynamic Phenotypes of Cardiac Surgery

NCT07085208

Phenotyping Machine Learning Cardiac Surgery +1 more

COMPLETED

Development of a Prediction Model for Intraoperative Blood Pressure Variability

NCT05698433

Blood Pressure Immeasurable

COMPLETED

Association of the Arteriovenous Difference in Carbon Dioxide and Its Relation to the Difference in Arteriovenous Oxygen Content With the Occurrence of Postoperative Complication

NCT03914976

Surgery--Complications

COMPLETED

Prediction of Complications After Major Gastrointestinal Surgery With Machine Learning and Point of Care Ultrasound

NCT06166719

Surgery-Complications Overload Fluid

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Lay Summary

Introduction: The World Health Organization estimates that 270-360 million operations are performed every year worldwide. Death and complications after surgery are a big challenge. In Canada, out of every 1000 major surgeries, 16 patients die in hospital after surgery. In the United States, for every 1000 operations, 67 patients unexpectedly need life support in the Intensive Care Unit. With population aging and limited resources, strategies to improve health after surgery are ever more important.

Vital signs, such as blood pressure and heart rate, show how the body is doing. Vital signs change during surgery because of patient, surgical, and anesthetic factors. Anesthesiologists can change vital signs with medications. However, medical professionals are only starting to understand which, and what ranges of, vital signs under anesthesia are associated with better health. Machine learning is a tool that can provide new ways to understand data. With better understanding, medical professionals can work to improve outcomes after surgery.

Objective: This study will analyze vital signs during surgeries for their links to death, complications (heart, lung, kidney, brain, infection), Intensive Care Unit admission, length of hospital stay, and hospital readmission. This study will determine which, and what levels of, vital signs may be harmful. The investigators predict that blood pressure, heart rate, oxygen level, carbon dioxide level, and the need for medications to change blood pressure will interact to be associated with death after surgery.

Methods: After obtaining Research Ethics Board approval, the investigators will analyze data from all patients who are at least 45 years old and had an operation (with the exception of heart surgery) with an overnight stay at the Queen Elizabeth II health centre (Halifax, Canada) from January 1, 2013 to December 1, 2017. There are approximately eligible 35,000 patients. The investigators will use machine learning to model the data and test how well our model explains outcomes after surgery.

Significance: The use of machine learning in a large, broad surgery population dataset could detect new relationships and strategies that may inform current practice, and generate ideas for future research. A better understanding of the impact of vital signs during surgeries may unveil methods to improve outcomes and resource allocation after surgery. The results may suggest ways to identify high-risk patients who should be monitored more closely after surgery. If the model performs well, it may motivate other researchers to use machine learning in health data research.

Please see full protocol for details.

May 2020 update (prior to dataset aggregation and analysis)

1. Added secondary outcome (days alive and out of hospital at 30 days postoperatively)
2. Improved hemodynamic variable artifact processing algorithm
3. Added sub-study: machine learning for invasive blood pressure artifact removal algorithm

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Perioperative/Postoperative Complications Morbidity, Multiple Surgery Anesthesia Death

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cohort

Patients ages ≥ 45 receiving their index (i.e. first) non-cardiac surgery with an overnight stay at the Nova Scotia Health Authority Queen Elizabeth II (QEII) hospitals (Victoria General and Halifax Infirmary) Halifax, Canada, from January 1, 2013 to December 1, 2017 will be included. Patients under going cardiac surgery or deceased organ donation will be excluded. Patients without an electronic anesthetic record during surgery will also be excluded. Preliminary analysis of the intraoperative database estimates approximately 35,000 patients in this cohort.

Blood pressure

Intervention Type OTHER

Systolic Blood Pressure (SBP)

1. Maximum change from preoperative SBP, in a) absolute change (mmHg), and b) relative change (%)(emergency and elective cases analyzed separately)
2. Cumulative duration (minutes) \>=20% below preoperative SBP
3. Longest single episode (minutes) below a) 80, b) 90, and c)100 mmHg
4. Cumulative duration (minutes) below a) 80, b) 90, and c)100 mmHg

Mean Arterial Pressure (MAP)

1. Maximum change from preoperative MAP, in a) absolute change (mmHg), and b) relative change (%) (emergency and elective cases analyzed separately)
2. Cumulative duration (minutes) \>=20% below preoperative MAP
3. Longest single episode (minutes) below a) 60, b) 65, c) 70, and d) 80mmHg
4. Cumulative duration (minutes) below a) 60, b) 65, c) 70, and d) 80mmHg

Heart rate

Intervention Type OTHER

1. Maximum change (beats per minute, BPM) from preoperative heart rate (positive and negative)
2. Relative change (%) from preoperative heart rate (positive and negative)
3. Maximum pulse variation (maximum heart rate minus minimum heart rate)
4. Longest single episode (minutes) a) below 60, and b) above 100BPM
5. Cumulative duration (minutes) a) below 60, and b) above 100BPM

Use of hemodynamic medications (i.e. special medications for blood pressure)

Intervention Type OTHER

1. Vasopressor/inotrope use (yes vs. no): phenylephrine, norepinephrine, epinephrine, vasopressin, dobutamine, or milrinone
2. Infusion of any vasopressor/inotropes above (yes vs. no) (identified by unit of weight over time)
3. Phenylephrine/ephedrine bolus (yes vs. no) (identified by unit of weight only)
4. Vasodilator use (yes vs. no): labetalol, esmolol, nitroglycerin, nitroprusside
5. Infusion of any vasodilator above (yes vs. no) (identified by unit of weight over time)

Oxygen saturation by pulse oximetry (SpO2)

Intervention Type OTHER

1. Longest single episode (minutes) below a) 88, and b) 90%
2. Cumulative duration (minutes) below a) 88, and b) 90%

End-tidal Carbon dioxide (EtCO2)

Intervention Type OTHER

1. Longest single episode (minutes) a) below 30, and b) above 45mmHg
2. Cumulative duration (minutes) a) below 30, and b) above 45mmHg

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Blood pressure

Systolic Blood Pressure (SBP)

1. Maximum change from preoperative SBP, in a) absolute change (mmHg), and b) relative change (%)(emergency and elective cases analyzed separately)
2. Cumulative duration (minutes) \>=20% below preoperative SBP
3. Longest single episode (minutes) below a) 80, b) 90, and c)100 mmHg
4. Cumulative duration (minutes) below a) 80, b) 90, and c)100 mmHg

Mean Arterial Pressure (MAP)

1. Maximum change from preoperative MAP, in a) absolute change (mmHg), and b) relative change (%) (emergency and elective cases analyzed separately)
2. Cumulative duration (minutes) \>=20% below preoperative MAP
3. Longest single episode (minutes) below a) 60, b) 65, c) 70, and d) 80mmHg
4. Cumulative duration (minutes) below a) 60, b) 65, c) 70, and d) 80mmHg

Intervention Type OTHER

Heart rate

1. Maximum change (beats per minute, BPM) from preoperative heart rate (positive and negative)
2. Relative change (%) from preoperative heart rate (positive and negative)
3. Maximum pulse variation (maximum heart rate minus minimum heart rate)
4. Longest single episode (minutes) a) below 60, and b) above 100BPM
5. Cumulative duration (minutes) a) below 60, and b) above 100BPM

Intervention Type OTHER

Use of hemodynamic medications (i.e. special medications for blood pressure)

1. Vasopressor/inotrope use (yes vs. no): phenylephrine, norepinephrine, epinephrine, vasopressin, dobutamine, or milrinone
2. Infusion of any vasopressor/inotropes above (yes vs. no) (identified by unit of weight over time)
3. Phenylephrine/ephedrine bolus (yes vs. no) (identified by unit of weight only)
4. Vasodilator use (yes vs. no): labetalol, esmolol, nitroglycerin, nitroprusside
5. Infusion of any vasodilator above (yes vs. no) (identified by unit of weight over time)

Intervention Type OTHER

Oxygen saturation by pulse oximetry (SpO2)

1. Longest single episode (minutes) below a) 88, and b) 90%
2. Cumulative duration (minutes) below a) 88, and b) 90%

Intervention Type OTHER

End-tidal Carbon dioxide (EtCO2)

1. Longest single episode (minutes) a) below 30, and b) above 45mmHg
2. Cumulative duration (minutes) a) below 30, and b) above 45mmHg

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All patients ages ≥ 45 receiving their index (i.e. first) non-cardiac surgery with an overnight stay at the Nova Scotia Health Authority Queen Elizabeth II (QEII) hospitals (Victoria General and Halifax Infirmary) Halifax, Canada, from January 1, 2013 to December 1, 2017.
* For patients who had multiple surgeries, only the first non-cardiac surgery with an overnight stay at QEII will be included to avoid confounding from previous surgical admissions (i.e. one surgical admission per patient).